ID   SSH1_HUMAN              Reviewed;        1049 AA.
AC   Q8WYL5; Q6P6C0; Q8N9A7; Q8WYL3; Q8WYL4; Q9P2P8;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 2.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Protein phosphatase Slingshot homolog 1;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=SSH-like protein 1;
DE            Short=SSH-1L;
DE            Short=hSSH-1L;
GN   Name=SSH1; Synonyms=KIAA1298, SSH1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION,
RP   INTERACTION WITH ACTIN, AND MUTAGENESIS OF CYS-393.
RX   PubMed=11832213; DOI=10.1016/S0092-8674(01)00638-9;
RA   Niwa R., Nagata-Ohashi K., Takeichi M., Mizuno K., Uemura T.;
RT   "Control of actin reorganization by Slingshot, a family of
RT   phosphatases that dephosphorylate ADF/cofilin.";
RL   Cell 108:233-246(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH ACTIN.
RX   PubMed=14531860; DOI=10.1046/j.1365-2443.2003.00678.x;
RA   Ohta Y., Kousaka K., Nagata-Ohashi K., Ohashi K., Muramoto A.,
RA   Shima Y., Niwa R., Uemura T., Mizuno K.;
RT   "Differential activities, subcellular distribution and tissue
RT   expression patterns of three members of Slingshot family phosphatases
RT   that dephosphorylate cofilin.";
RL   Genes Cells 8:811-824(2003).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   CYS-393.
RX   PubMed=12807904; DOI=10.1074/jbc.M305802200;
RA   Kaji N., Ohashi K., Shuin M., Niwa R., Uemura T., Mizuno K.;
RT   "Cell cycle-associated changes in Slingshot phosphatase activity and
RT   roles in cytokinesis in animal cells.";
RL   J. Biol. Chem. 278:33450-33455(2003).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF CYS-393.
RX   PubMed=12684437;
RA   Endo M., Ohashi K., Sasaki Y., Goshima Y., Niwa R., Uemura T.,
RA   Mizuno K.;
RT   "Control of growth cone motility and morphology by LIM kinase and
RT   Slingshot via phosphorylation and dephosphorylation of cofilin.";
RL   J. Neurosci. 23:2527-2537(2003).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-393.
RX   PubMed=15056216; DOI=10.1111/j.1462-5822.2004.00375.x;
RA   Dai S., Sarmiere P.D., Wiggan O., Bamburg J.R., Zhou D.;
RT   "Efficient Salmonella entry requires activity cycles of host ADF and
RT   cofilin.";
RL   Cell. Microbiol. 6:459-471(2004).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=14645219; DOI=10.1074/jbc.M312591200;
RA   Nishita M., Wang Y., Tomizawa C., Suzuki A., Niwa R., Uemura T.,
RA   Mizuno K.;
RT   "Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase
RT   Slingshot and its role for insulin-induced membrane protrusion.";
RL   J. Biol. Chem. 279:7193-7198(2004).
RN   [10]
RP   FUNCTION, INTERACTION WITH YWHAB; YWHAG; YWHAQ AND YWHAZ, SUBCELLULAR
RP   LOCATION, PHOSPHORYLATION AT SER-978, AND MUTAGENESIS OF CYS-393;
RP   SER-937 AND SER-978.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [11]
RP   FUNCTION, INTERACTION WITH ACTIN; LIMK1 AND YWHAZ, PHOSPHORYLATION,
RP   AND MUTAGENESIS OF CYS-393.
RX   PubMed=15660133; DOI=10.1038/sj.emboj.7600543;
RA   Soosairajah J., Maiti S., Wiggan O., Sarmiere P., Moussi N.,
RA   Sarcevic B., Sampath R., Bamburg J.R., Bernard O.;
RT   "Interplay between components of a novel LIM kinase-slingshot
RT   phosphatase complex regulates cofilin.";
RL   EMBO J. 24:473-486(2005).
RN   [12]
RP   FUNCTION, PHOSPHORYLATION, DEPHOSPHORYLATION BY PPP3CA, AND
RP   MUTAGENESIS OF CYS-393.
RX   PubMed=15671020; DOI=10.1074/jbc.M411494200;
RA   Wang Y., Shibasaki F., Mizuno K.;
RT   "Calcium signal-induced cofilin dephosphorylation is mediated by
RT   Slingshot via calcineurin.";
RL   J. Biol. Chem. 280:12683-12689(2005).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-393 AND
RP   TRP-458.
RX   PubMed=16230460; DOI=10.1083/jcb.200504029;
RA   Nishita M., Tomizawa C., Yamamoto M., Horita Y., Ohashi K., Mizuno K.;
RT   "Spatial and temporal regulation of cofilin activity by LIM kinase and
RT   Slingshot is critical for directional cell migration.";
RL   J. Cell Biol. 171:349-359(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-57, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576 AND SER-897, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Protein phosphatase which regulates actin filament
CC       dynamics. Dephosphorylates and activates the actin
CC       binding/depolymerizing factor cofilin, which subsequently binds to
CC       actin filaments and stimulates their disassembly. Inhibitory
CC       phosphorylation of cofilin is mediated by LIMK1, which may also be
CC       dephosphorylated and inactivated by this protein.
CC       {ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:12684437,
CC       ECO:0000269|PubMed:12807904, ECO:0000269|PubMed:14531860,
CC       ECO:0000269|PubMed:14645219, ECO:0000269|PubMed:15056216,
CC       ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133,
CC       ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:16230460}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBUNIT: Interacts with actin and this stimulates phosphatase
CC       activity. Also interacts with LIMK1 and with the 14-3-3 proteins
CC       YWHAB, YWHAG, YWHAQ, and YWHAZ. Interaction with 14-3-3 proteins
CC       inhibits phosphatase activity and also blocks recruitment to
CC       lamellipodia and stimulation by actin.
CC       {ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:14531860,
CC       ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133}.
CC   -!- INTERACTION:
CC       P23528:CFL1; NbExp=2; IntAct=EBI-1222387, EBI-352733;
CC       Q9BR76:CORO1B; NbExp=3; IntAct=EBI-1222387, EBI-351152;
CC       P53667:LIMK1; NbExp=7; IntAct=EBI-1222387, EBI-444403;
CC       P31946:YWHAB; NbExp=3; IntAct=EBI-1222387, EBI-359815;
CC       P27348:YWHAQ; NbExp=2; IntAct=EBI-1222387, EBI-359854;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cell projection,
CC       lamellipodium. Cleavage furrow. Midbody. Note=Also recruited to
CC       actin rich membrane protrusions such as lamellipodia, which may
CC       allow local control of actin dynamics at sites of cell locomotion.
CC       Also localized to the cleavage furrow and the midbody during
CC       cytokinesis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=L;
CC         IsoId=Q8WYL5-1; Sequence=Displayed;
CC       Name=2; Synonyms=S;
CC         IsoId=Q8WYL5-2; Sequence=VSP_016318, VSP_016319;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3; Synonyms=B;
CC         IsoId=Q8WYL5-3; Sequence=VSP_016312, VSP_016314, VSP_016315,
CC                                  VSP_016316;
CC         Note=Due to intron retention. No experimental confirmation
CC         available.;
CC       Name=4;
CC         IsoId=Q8WYL5-4; Sequence=VSP_016311, VSP_016317;
CC       Name=5;
CC         IsoId=Q8WYL5-5; Sequence=VSP_016313, VSP_016318, VSP_016319;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated. Inhibitory phosphorylation by PAK4 promotes
CC       binding to YWHAZ. Phosphorylation at Ser-978 is decreased by
CC       stimuli which promote actin reorganization and lamellipodia
CC       formation. Can be dephosphorylated and activated by
CC       PPP3CA/calcineurin A. Phosphorylation decreases immediately prior
CC       to telophase. {ECO:0000269|PubMed:12807904,
CC       ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133,
CC       ECO:0000269|PubMed:15671020}.
CC   -!- MISCELLANEOUS: Tyrosine phosphatase activity has not been
CC       demonstrated for this protein to date.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92536.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB072355; BAB84114.1; -; mRNA.
DR   EMBL; AB072356; BAB84115.1; -; mRNA.
DR   EMBL; AB072357; BAB84116.1; -; mRNA.
DR   EMBL; AB037719; BAA92536.1; ALT_INIT; mRNA.
DR   EMBL; AK095421; BAC04546.1; -; mRNA.
DR   EMBL; BC062341; AAH62341.1; -; mRNA.
DR   CCDS; CCDS53825.1; -. [Q8WYL5-5]
DR   CCDS; CCDS55882.1; -. [Q8WYL5-2]
DR   CCDS; CCDS9121.1; -. [Q8WYL5-1]
DR   RefSeq; NP_001154802.1; NM_001161330.1. [Q8WYL5-2]
DR   RefSeq; NP_001154803.1; NM_001161331.1. [Q8WYL5-5]
DR   RefSeq; NP_061857.3; NM_018984.3. [Q8WYL5-1]
DR   RefSeq; XP_016874982.1; XM_017019493.1. [Q8WYL5-4]
DR   RefSeq; XP_016874983.1; XM_017019494.1. [Q8WYL5-4]
DR   UniGene; Hs.199763; -.
DR   ProteinModelPortal; Q8WYL5; -.
DR   SMR; Q8WYL5; -.
DR   BioGrid; 119950; 14.
DR   IntAct; Q8WYL5; 13.
DR   MINT; MINT-1788740; -.
DR   STRING; 9606.ENSP00000315713; -.
DR   DEPOD; Q8WYL5; -.
DR   iPTMnet; Q8WYL5; -.
DR   PhosphoSitePlus; Q8WYL5; -.
DR   BioMuta; SSH1; -.
DR   DMDM; 82582267; -.
DR   EPD; Q8WYL5; -.
DR   MaxQB; Q8WYL5; -.
DR   PaxDb; Q8WYL5; -.
DR   PeptideAtlas; Q8WYL5; -.
DR   PRIDE; Q8WYL5; -.
DR   DNASU; 54434; -.
DR   Ensembl; ENST00000326470; ENSP00000326107; ENSG00000084112. [Q8WYL5-5]
DR   Ensembl; ENST00000326495; ENSP00000315713; ENSG00000084112. [Q8WYL5-1]
DR   Ensembl; ENST00000551165; ENSP00000448824; ENSG00000084112. [Q8WYL5-2]
DR   GeneID; 54434; -.
DR   KEGG; hsa:54434; -.
DR   UCSC; uc001tnm.4; human. [Q8WYL5-1]
DR   CTD; 54434; -.
DR   DisGeNET; 54434; -.
DR   GeneCards; SSH1; -.
DR   HGNC; HGNC:30579; SSH1.
DR   HPA; HPA019845; -.
DR   MIM; 606778; gene.
DR   neXtProt; NX_Q8WYL5; -.
DR   OpenTargets; ENSG00000084112; -.
DR   PharmGKB; PA134941788; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00760000118902; -.
DR   HOGENOM; HOG000154427; -.
DR   HOVERGEN; HBG094001; -.
DR   InParanoid; Q8WYL5; -.
DR   KO; K05766; -.
DR   OMA; NSHCDKN; -.
DR   OrthoDB; EOG091G0249; -.
DR   PhylomeDB; Q8WYL5; -.
DR   TreeFam; TF319444; -.
DR   SIGNOR; Q8WYL5; -.
DR   ChiTaRS; SSH1; human.
DR   GeneWiki; SSH1; -.
DR   GenomeRNAi; 54434; -.
DR   PRO; PR:Q8WYL5; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000084112; -.
DR   CleanEx; HS_SSH1; -.
DR   ExpressionAtlas; Q8WYL5; baseline and differential.
DR   Genevisible; Q8WYL5; HS.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0000902; P:cell morphogenesis; IMP:UniProtKB.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:MGI.
DR   GO; GO:0098976; P:excitatory chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:1904719; P:positive regulation of AMPA glutamate receptor clustering; IEA:Ensembl.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:1901216; P:positive regulation of neuron death; IEA:Ensembl.
DR   GO; GO:0031915; P:positive regulation of synaptic plasticity; IEA:Ensembl.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0008064; P:regulation of actin polymerization or depolymerization; IBA:GO_Central.
DR   GO; GO:0050770; P:regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0032268; P:regulation of cellular protein metabolic process; IDA:MGI.
DR   GO; GO:0010591; P:regulation of lamellipodium assembly; IBA:GO_Central.
DR   CDD; cd00127; DSPc; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR014876; DEK_C.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR027233; SSH1.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10159; PTHR10159; 1.
DR   PANTHER; PTHR10159:SF434; PTHR10159:SF434; 1.
DR   Pfam; PF08766; DEK_C; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Cell projection;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Hydrolase; Phosphoprotein;
KW   Protein phosphatase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2   1049       Protein phosphatase Slingshot homolog 1.
FT                                /FTId=PRO_0000094841.
FT   DOMAIN      308    448       Tyrosine-protein phosphatase.
FT   REGION      897   1049       Interaction with YWHAG.
FT                                {ECO:0000269|PubMed:15159416}.
FT   ACT_SITE    393    393       Phosphocysteine intermediate.
FT                                {ECO:0000305}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      57     57       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     515    515       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q76I79}.
FT   MOD_RES     576    576       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     897    897       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     978    978       Phosphoserine.
FT                                {ECO:0000269|PubMed:15159416}.
FT   VAR_SEQ       1    312       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10718198}.
FT                                /FTId=VSP_016311.
FT   VAR_SEQ       1     73       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11832213}.
FT                                /FTId=VSP_016312.
FT   VAR_SEQ       1     37       MALVTLQRSPTPSAASSSASNSELEAGSEEDRKLNLS ->
FT                                MARARRAVVGSVRDVSTAATNLFYFTDFCIFLQPTHCFCCP
FT                                EVSSSNY (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016313.
FT   VAR_SEQ      74     93       LPQHLQVMINLLRCEDRIKL -> MGGRHHLQRQVSESMSA
FT                                LFQ (in isoform 3).
FT                                {ECO:0000303|PubMed:11832213}.
FT                                /FTId=VSP_016314.
FT   VAR_SEQ     135    157       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11832213}.
FT                                /FTId=VSP_016315.
FT   VAR_SEQ     245   1049       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11832213}.
FT                                /FTId=VSP_016316.
FT   VAR_SEQ     313    334       FDHLYLGSEWNASNLEELQGSG -> MRCYLSWDRWTSPPL
FT                                SSIIFIS (in isoform 4).
FT                                {ECO:0000303|PubMed:10718198}.
FT                                /FTId=VSP_016317.
FT   VAR_SEQ     632    692       DDAIFGILNKVKPSYKSCADCMYPTASGAPEASRERCEDPN
FT                                APAICTQPAFLPHITSSPVA -> VGRARPAGWHTPSLPSH
FT                                SNWPTSASVVGTTGTRHHTQLIFFYCLLWAPSSHLQGPEGS
FT                                FTG (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:11832213,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016318.
FT   VAR_SEQ     693   1049       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:11832213,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016319.
FT   MUTAGEN     393    393       C->S: Abrogates phosphatase activity.
FT                                {ECO:0000269|PubMed:11832213,
FT                                ECO:0000269|PubMed:12684437,
FT                                ECO:0000269|PubMed:12807904,
FT                                ECO:0000269|PubMed:15056216,
FT                                ECO:0000269|PubMed:15159416,
FT                                ECO:0000269|PubMed:15660133,
FT                                ECO:0000269|PubMed:15671020,
FT                                ECO:0000269|PubMed:16230460}.
FT   MUTAGEN     458    458       W->A: Impairs stimulation of phosphatase
FT                                activity by actin but does not affect
FT                                basal activity.
FT                                {ECO:0000269|PubMed:16230460}.
FT   MUTAGEN     937    937       S->A: Reduces binding to YWHAB, YWHAG,
FT                                YWHAQ and YWHAZ. Abolishes binding to
FT                                YWHAB, YWHAG, YWHAQ and YWHAZ and
FT                                increases association with F-actin; when
FT                                associated with A-978.
FT                                {ECO:0000269|PubMed:15159416}.
FT   MUTAGEN     978    978       S->A: Reduces binding to YWHAB, YWHAG,
FT                                YWHAQ and YWHAZ. Abolishes binding to
FT                                YWHAB, YWHAG, YWHAQ and YWHAZ and
FT                                increases association with F-actin; when
FT                                associated with A-937.
FT                                {ECO:0000269|PubMed:15159416}.
FT   CONFLICT      2      2       A -> V (in Ref. 4; AAH62341).
FT                                {ECO:0000305}.
FT   CONFLICT    230    230       L -> P (in Ref. 1; BAB84116).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1049 AA;  115511 MW;  0600B9690F0E6F9C CRC64;
     MALVTLQRSP TPSAASSSAS NSELEAGSEE DRKLNLSLSE SFFMVKGAAL FLQQGSSPQG
     QRSLQHPHKH AGDLPQHLQV MINLLRCEDR IKLAVRLESA WADRVRYMVV VYSSGRQDTE
     ENILLGVDFS SKESKSCTIG MVLRLWSDTK IHLDGDGGFS VSTAGRMHIF KPVSVQAMWS
     ALQVLHKACE VARRHNYFPG GVALIWATYY ESCISSEQSC INEWNAMQDL ESTRPDSPAL
     FVDKPTEGER TERLIKAKLR SIMMSQDLEN VTSKEIRNEL EKQMNCNLKE LKEFIDNEML
     LILGQMDKPS LIFDHLYLGS EWNASNLEEL QGSGVDYILN VTREIDNFFP GLFAYHNIRV
     YDEETTDLLA HWNEAYHFIN KAKRNHSKCL VHCKMGVSRS ASTVIAYAMK EFGWPLEKAY
     NYVKQKRSIT RPNAGFMRQL SEYEGILDAS KQRHNKLWRQ QTDSSLQQPV DDPAGPGDFL
     PETPDGTPES QLPFLDDAAQ PGLGPPLPCC FRRLSDPLLP SPEDETGSLV HLEDPEREAL
     LEEAAPPAEV HRPARQPQQG SGLCEKDVKK KLEFGSPKGR SGSLLQVEET EREEGLGAGR
     WGQLPTQLDQ NLLNSENLNN NSKRSCPNGM EDDAIFGILN KVKPSYKSCA DCMYPTASGA
     PEASRERCED PNAPAICTQP AFLPHITSSP VAHLASRSRV PEKPASGPTE PPPFLPPAGS
     RRADTSGPGA GAALEPPASL LEPSRETPKV LPKSLLLKNS HCDKNPPSTE VVIKEESSPK
     KDMKPAKDLR LLFSNESEKP TTNSYLMQHQ ESIIQLQKAG LVRKHTKELE RLKSVPADPA
     PPSRDGPASR LEASIPEESQ DPAALHELGP LVMPSQAGSD EKSEAAPASL EGGSLKSPPP
     FFYRLDHTSS FSKDFLKTIC YTPTSSSMSS NLTRSSSSDS IHSVRGKPGL VKQRTQEIET
     RLRLAGLTVS SPLKRSHSLA KLGSLTFSTE DLSSEADPST VADSQDTTLS ESSFLHEPQG
     TPRDPAATSK PSGKPAPENL KSPSWMSKS
//
